Staphylococcal infections.

Research output: Contribution to journalArticle

Original languageUndefined/Unknown
Pages (from-to)198-201
Number of pages4
JournalCurrent Opinion in Infectious Diseases
Volume2
Issue number2
StatePublished - 1989

Keywords

  • antibiotic resistance
  • coagulase negative Staphylococcus
  • coagulase positive Staphylococcus
  • drug research
  • drug resistance
  • human
  • nonhuman
  • prophylaxis
  • short survey
  • Staphylococcus aureus
  • Staphylococcus infection/di [Diagnosis]
  • Staphylococcus infection/dt [Drug Therapy]
  • Staphylococcus infection/ep [Epidemiology]
  • Staphylococcus infection/et [Etiology]
  • Staphylococcus infection/pc [Prevention]
  • Staphylococcus infection/th [Therapy]
  • beta lactam antibiotic/dt [Drug Therapy]
  • cilastatin plus imipenem
  • ciprofloxacin/dv [Drug Development]
  • ciprofloxacin/pd [Pharmacology]
  • imipenem/dv [Drug Development]
  • imipenem/pd [Pharmacology]
  • pseudomonic acid/dv [Drug Development]
  • pseudomonic acid/pd [Pharmacology]
  • teicoplanin/dv [Drug Development]
  • teicoplanin/pd [Pharmacology]
  • vancomycin/dt [Drug Therapy]

Cite this

Staphylococcal infections. / Sabath, L. D.

In: Current Opinion in Infectious Diseases, Vol. 2, No. 2, 1989, p. 198-201.

Research output: Contribution to journalArticle

@article{5e1293a088cd48e2bece730fb1101397,
title = "Staphylococcal infections.",
keywords = "antibiotic resistance, coagulase negative Staphylococcus, coagulase positive Staphylococcus, drug research, drug resistance, human, nonhuman, prophylaxis, short survey, Staphylococcus aureus, Staphylococcus infection/di [Diagnosis], Staphylococcus infection/dt [Drug Therapy], Staphylococcus infection/ep [Epidemiology], Staphylococcus infection/et [Etiology], Staphylococcus infection/pc [Prevention], Staphylococcus infection/th [Therapy], beta lactam antibiotic/dt [Drug Therapy], cilastatin plus imipenem, ciprofloxacin/dv [Drug Development], ciprofloxacin/pd [Pharmacology], imipenem/dv [Drug Development], imipenem/pd [Pharmacology], pseudomonic acid/dv [Drug Development], pseudomonic acid/pd [Pharmacology], teicoplanin/dv [Drug Development], teicoplanin/pd [Pharmacology], vancomycin/dt [Drug Therapy]",
author = "Sabath, {L. D.}",
year = "1989",
language = "Undefined/Unknown",
volume = "2",
pages = "198--201",
journal = "Current Opinion in Infectious Diseases",
issn = "0951-7375",
publisher = "Lippincott Williams and Wilkins",
number = "2",

}

TY - JOUR

T1 - Staphylococcal infections.

AU - Sabath, L. D.

PY - 1989

Y1 - 1989

KW - antibiotic resistance

KW - coagulase negative Staphylococcus

KW - coagulase positive Staphylococcus

KW - drug research

KW - drug resistance

KW - human

KW - nonhuman

KW - prophylaxis

KW - short survey

KW - Staphylococcus aureus

KW - Staphylococcus infection/di [Diagnosis]

KW - Staphylococcus infection/dt [Drug Therapy]

KW - Staphylococcus infection/ep [Epidemiology]

KW - Staphylococcus infection/et [Etiology]

KW - Staphylococcus infection/pc [Prevention]

KW - Staphylococcus infection/th [Therapy]

KW - beta lactam antibiotic/dt [Drug Therapy]

KW - cilastatin plus imipenem

KW - ciprofloxacin/dv [Drug Development]

KW - ciprofloxacin/pd [Pharmacology]

KW - imipenem/dv [Drug Development]

KW - imipenem/pd [Pharmacology]

KW - pseudomonic acid/dv [Drug Development]

KW - pseudomonic acid/pd [Pharmacology]

KW - teicoplanin/dv [Drug Development]

KW - teicoplanin/pd [Pharmacology]

KW - vancomycin/dt [Drug Therapy]

M3 - Article

VL - 2

SP - 198

EP - 201

JO - Current Opinion in Infectious Diseases

JF - Current Opinion in Infectious Diseases

SN - 0951-7375

IS - 2

ER -